about
Acute arterial thrombosis after escalated-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy with recombinant granulocyte colony-stimulating factor. A possible new recombinant granulocyte colony-stimulating factor toxicityDiabetes mellitus is associated with shortened activated partial thromboplastin time and increased fibrinogen valuesHypercoagulability in a patient with Marfan syndromeAntithrombotic therapy for prosthetic valves: routine treatment and special considerations.Hemostatic changes in patients with malignancy.Platelet parameters in healthy and pathological pregnancy.A 61-year-old man with extensive thrombosis.The relationship between ischemic stroke and weather conditions in Duzce, Turkey.Cisplatin, 5-fluorouracil, and etoposide for advanced non-small cell lung cancer.Disordered hemostasis in extrahepatic portal hypertension.Homocystinuria presenting as central retinal artery occlusion and longstanding thromboembolic diseaseDeep vein thrombosis and tuberculosis: a causative link?Venous thromboembolism in paediatric practice.Ischemic strokes in children.Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.Valve prostheses and pregnancyStroke in young people--the heart of the matterPulmonary embolism as a complication of long-term total parenteral nutrition.Hypercoagulable state testing and malignancy screening following venous thromboembolic events.Clinical use of the low-molecular-weight heparins in cancer patients: focus on the improved patient outcomes.Two urinary peptides associated closely with type 2 diabetes mellitus.Indications for thrombolytic therapy in acute pulmonary embolism.Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus.Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure.Maternal and Fetal Outcomes in Pregnant Women with a Prosthetic Mechanical Heart ValveRecent advances in the treatment of thromboembolic diseases: venous thromboembolism.Outcome of pregnancy in women with valve prostheses.Acquired hemostatic abnormalities in the elderly.Congenital thrombotic disorders.Cardiac valve prostheses: pathological and bioengineering considerations.Venous thromboembolism: epidemiology, diagnosis, prevention.Mendelian etiologies of stroke.Cerebral infarction in patient with minimal change nephrotic syndrome.Oral contraceptives. The benefits and the cardiovascular risks.Effects of teneligliptin on PDMPs and PAI-1 in patients with diabetes on hemodialysis.Venous thromboembolism in neurosurgery and neurology patients: a review.Paraneoplastic cholestasis and hypercoagulability associated with medullary thyroid carcinoma. Resolution with tumor debulking.Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus.A Case of Transient Ischemic Attack in a patient with Ulcerative Colitis.Family planning requirements of adults with congenital heart disease.
P2860
Q28316459-1EFE9665-21B3-4E80-A63F-F4EBABF55153Q28743200-AC6E9FB6-5E39-41BD-B54B-490DA59FE7FAQ30443053-9A063365-7EFD-45FC-92EF-4126B67B027FQ31805137-E9464158-0B30-4A03-A052-F306521D8F49Q33337433-7724E270-23DF-497C-9CCF-A0B421D7E41FQ33415369-5D80B885-9DA6-4AB3-8165-6E2777AE680DQ33448391-C4198F6C-DD77-49E9-A1B7-5D4FE13C62E4Q33466163-CFF6824B-2542-4814-B83D-A9526D30D8DBQ33494026-6C3D7E07-A205-4882-BDEF-69CF5E0E56D3Q33494171-09F2F66A-EAB8-48B8-A50B-5D6CC5BBCB82Q33648442-240FC21E-B500-4C69-B5F0-40194DB45BEFQ33691349-E5F31F4D-AD5A-4FA7-B350-0BDAA641D159Q33794116-B407636D-9C0A-40D1-BC19-84B508C0D341Q33894851-D4458099-8947-4510-9E5C-44F69E6118CDQ34086042-CB86230B-930C-453D-B020-8B7D8CBA6D69Q34118406-C27BA952-FB1C-4A34-9ED4-AD176B9255ABQ34195498-A3965606-5B76-4E18-AB09-F472B0540CC2Q34349188-1DE4D33D-3ED6-4B3D-9F23-58F6189F27B9Q35179215-5CD9F672-BFD6-42D4-BF05-EC3909889B28Q35368813-EADFBC84-13A7-4DE4-B26D-3F884084B41BQ35527005-F5C3C6B6-C028-402D-AF7F-917234C9E66AQ35640900-49D808C6-6432-4C64-8D50-54851D9D327DQ35914764-5CBB061F-D7D1-4075-9648-0F99A7DB5DBBQ36491882-710F449B-D4CD-49B1-B59A-1058DCE7D4EBQ36572602-3E417733-84E3-47CE-AE56-3225E65AA3C7Q36743749-0FB8FA0E-1970-49C0-892D-B4DD6079B5FFQ36812343-A86800D2-A560-48FE-9E3A-68F889E2527FQ37941240-695DF506-C18C-4085-B3B0-8B92CFABBCABQ39477853-003A906B-B08B-4C83-8564-DF2ECABBC9F2Q39491443-D45DD461-DA51-42F8-9B5C-BEE98BA65A89Q39592542-61EC4B1E-7923-4A58-97D4-48A55F5B7DD8Q39672446-A6503B41-8176-4C60-B0D1-233AF179B2E8Q39712869-7EEE5054-A7BA-49AA-A876-1D5AE0B3F0A9Q39755678-10F7127B-13B7-4598-B869-14E6323832F4Q40294653-7C8714DF-01E0-4CF7-8C21-8D16FF3D42D2Q40749842-15825E32-58AD-4B2E-9E3C-A792DC77ED04Q40810003-BC5DD382-B70D-4986-906B-00B0AC8F13A8Q42121320-2F3846CC-EC44-4EF6-87AC-DB28B968D1F2Q42181165-415CAE08-05E2-4577-99AF-9095087D0498Q42389988-121C8349-A565-4EA5-9D46-D21A562B8103
P2860
description
1985 nî lūn-bûn
@nan
1985 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
The hypercoagulable states.
@ast
The hypercoagulable states.
@en
type
label
The hypercoagulable states.
@ast
The hypercoagulable states.
@en
prefLabel
The hypercoagulable states.
@ast
The hypercoagulable states.
@en
P1476
The hypercoagulable states.
@en
P2093
A I Schafer
P304
P356
10.7326/0003-4819-102-6-814
P407
P577
1985-06-01T00:00:00Z